| Demystifying the Contemporary Role of 12-Month Dual Antiplatelet Therapy After Acute Coronary Syndrome M Valgimigli, A Landi, DJ Angiolillo, U Baber, DL Bhatt, MP Bonaca, ... Circulation 150 (4), 317-335, 2024 | | 2024 |
| Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiA RD Lopes, CB Granger, DM Wojdyla, WF McIntyre, M Alings, T Mani, ... Journal of the American College of Cardiology 84 (4), 354-364, 2024 | 2 | 2024 |
| Effect of Apixaban on Clinical Outcomes in Outpatients With COVID-19: The APOLLO Randomized Clinical Trial PGM de Barros e Silva, AVS Macedo, B Bronhara, LP Damiani, ... Circulation 150 (1), 82-85, 2024 | | 2024 |
| LB-469807-04 EFFICACY AND SAFETY OF APIXABAN VERSUS ASPIRIN ACCORDING TO CHA2DS2-VASC SCORE IN PATIENTS WITH SUBCLINICAL ATRIAL FIBRILLATION IN ARTESIA JS Healey, C Granger, WF McIntyre, M Alings, D Wojdyla, ... Heart Rhythm 21 (7), 1206-1207, 2024 | | 2024 |
| Guidelines on the Diagnosis and Treatment of Hypertrophic Cardiomyopathy–2024 F Fernandes, MV Simões, EB Correia, FG Marcondes-Braga, ... Arq. Bras. Cardiol. 121 (7), -, 2024 | | 2024 |
| Comparative Effectiveness and Safety of Apixaban and Rivaroxaban in Older Patients with Atrial Fibrillation: A Population-Based Cohort Study M Shurrab, PC Austin, CA Jackevicius, K Tu, F Qiu, O Haldenby, ... Heart Rhythm, 2024 | | 2024 |
| Antithrombotic Strategies According to Age: Insights From the AUGUSTUS Trial PO Guimarães, RD Lopes, DM Wojdyla, JH Alexander, SG Goodman, ... The American journal of medicine, 2024 | | 2024 |
| Left ventricular function, congestion, and effect of empagliflozin on heart failure risk after myocardial infarction JA Udell, MC Petrie, WS Jones, SD Anker, J Harrington, M Mattheus, ... Journal of the American College of Cardiology 83 (23), 2233-2246, 2024 | 4 | 2024 |
| Cardiology and oncology: a meeting of giants JPP Dutra, AVS Macedo, TFLF Peixoto, JDS Garcez, BC Bacchiega, ... Revista da Associação Médica Brasileira 70 (suppl 1), e2024S114, 2024 | | 2024 |
| Effect of reconstituted human apolipoprotein AI on recurrent ischemic events in survivors of acute MI TJ Povsic, S Korjian, MC Bahit, G Chi, D Duffy, JH Alexander, ... Journal of the American College of Cardiology 83 (22), 2163-2174, 2024 | 3 | 2024 |
| Cardiac Troponin and Treatment Effects of Omecamtiv Mecarbil: Results From the GALACTIC-HF Study GM Felker, SD Solomon, M Metra, JJV Mcmurray, R Diaz, B Claggett, ... Journal of cardiac failure 30 (6), 755-763, 2024 | | 2024 |
| The Atrial FibriLlatiOn (FLOW-AF) Registry in the Middle East and North Africa: Patient Characteristics, Treatment Patterns and Outcomes WA Almahmeed, A Hersi, N Khalife, MFS Gamaleldin, SA Kherraf, ... Advances in Therapy, 1-22, 2024 | | 2024 |
| Effect of empagliflozin on heart failure outcomes after acute myocardial infarction: insights from the EMPACT-MI trial AF Hernandez, JA Udell, WS Jones, SD Anker, MC Petrie, J Harrington, ... Circulation 149 (21), 1627-1638, 2024 | 11 | 2024 |
| Predictors of bleeding and thrombotic events among patients admitted to the hospital with COVID-19 and elevated D-dimer: insights from the ACTION randomized clinical trial PGM de Barros e Silva, RHM Furtado, MS de Alcântara Chaud, ... Journal of Thrombosis and Thrombolysis, 1-9, 2024 | | 2024 |
| Polyvascular Disease: A Narrative Review of Risk Factors, Clinical Outcomes and Treatment M Tannu, CN Hess, JA Gutierrez, R Lopes, RV Swaminathan, SE Altin, ... Current Cardiology Reports, 1-16, 2024 | | 2024 |
| Apolipoprotein A1 infusions and cardiovascular outcomes after acute myocardial infarction CM Gibson, D Duffy, S Korjian, MC Bahit, G Chi, JH Alexander, AM Lincoff, ... New England Journal of Medicine 390 (17), 1560-1571, 2024 | 15 | 2024 |
| MP-483492-006 APIXABAN VERSUS ASPIRIN FOR THE PREVENTION OF STROKE IN PATIENTS WITH SUBCLINICAL ATRIAL FIBRILLATION DETECTED BY AN IMPLANTED CARDIAC MONITOR: AN ANALYSIS OF THE … LY Xing, RD Lopes, WF McIntyre, C Granger, SJ Connolly, MR Gold, ... Heart Rhythm 21 (5), S63, 2024 | | 2024 |
| When to prescribe oral anticoagulation for patients with device-detected subclinical atrial fibrillation? Insights from the NOAH-AFNET 6 and ARTESiA trials WF McIntyre, JS Healey, RD Lopes European Journal of Internal Medicine 123, 52-54, 2024 | 1 | 2024 |
| Regional variation in cause of death in patients with type 2 diabetes: Insights from EXSCEL VN Rao, A Sharma, A Stebbins, JB Buse, BG Katona, NJ Pagidipati, ... American Heart Journal 271, 123-135, 2024 | | 2024 |
| Impact of age and comorbid heart failure on the utility of smart voice-assistant devices P Marques, A Emami, G Zhang, RD Lopes, A Razaghizad, R Avram, ... European Heart Journal-Digital Health 5 (3), 389-393, 2024 | | 2024 |
